CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-05 | Phanstiel S. Louise Director | Grant or award | +49,796 | 177,444 | ||
| 2025-06-05 | Newcomer Lee Nisley Director | Grant or award | +49,796 | 132,141 | ||
| 2025-06-05 | Reitan Colleen F Director | Grant or award | +49,796 | 92,329 | ||
| 2025-06-05 | Kumar Rashmi Director | Grant or award | +49,796 | 127,188 | ||
| 2025-06-05 | Skovronsky Daniel Director | Grant or award | +49,796 | 135,806 | ||
| 2025-05-31 | Raha Samraat S. President and CEO | Grant or award | +1,498 | $3.56 | $5K | 482,738 |
| 2025-05-01 | Donnelly Brian J Chief Commerical Officer | Grant or award | +269,905 | 269,905 | ||
| 2025-05-01 | Donnelly Brian J Chief Commerical Officer | Grant or award | +127,629 | 397,534 | ||
| 2025-05-01 | Donnelly Brian J Chief Commerical Officer | Grant or award · Performance-Based Restricted Stock Units | +236,167 | 236,167 | ||
| 2025-04-30 | Raha Samraat S. President and CEO | Grant or award · Performance-Based Restricted Stock Units | +141,050 | 141,050 | ||
| 2025-04-30 | Verratti Mark Chief Operating Officer | Grant or award · Performance-Based Restricted Stock Units | +105,785 | 105,785 | ||
| 2025-04-14 | Muzzey Dale Chief Scientific Officer | Shares withheld for taxes | −942 | $8.08 | $8K | 170,599 |
| 2025-04-14 | Verratti Mark Chief Commercial Officer | Shares withheld for taxes | −1,085 | $8.08 | $9K | 382,911 |
| 2025-03-25 | Munk Natalie Chief Accounting Officer | Shares withheld for taxes | −362 | $9.73 | $4K | 46,129 |
| 2025-03-24 | Munk Natalie Chief Accounting Officer | Shares withheld for taxes | −393 | $9.98 | $4K | 47,080 |
| 2025-03-24 | Munk Natalie Chief Accounting Officer | Shares withheld for taxes | −589 | $9.98 | $6K | 46,491 |
| 2025-03-24 | Haas Kevin Richard Chief Technology Officer | Shares withheld for taxes | −1,177 | $9.98 | $12K | 180,359 |
| 2025-03-24 | Haas Kevin Richard Chief Technology Officer | Shares withheld for taxes | −1,724 | $9.98 | $17K | 178,635 |
| 2025-03-24 | Muzzey Dale Chief Scientific Officer | Shares withheld for taxes | −545 | $9.98 | $5K | 172,341 |
| 2025-03-24 | Muzzey Dale Chief Scientific Officer | Shares withheld for taxes | −800 | $9.98 | $8K | 171,541 |
Page 5 of 15 · 286 trades